Program Overview
The Executive MBA at BBI Cambridge is meticulously designed for high-potential leaders at the intersection of biotechnology and finance. This intensive programme combines rigorous academic theory with practical, real-world applications, enabling participants to master the complexities of life sciences investment, strategic management, and corporate valuation.
Guided by world-class faculty and industry experts, you will gain a profound understanding of the global biotech ecosystem while cultivating the leadership skills necessary to drive innovation and sustainable growth in this rapidly evolving sector.
Program at a Glance
Starting Date
April 2026
Duration
18 Months
Average Age
35 Years
Class Size
25–30 Students
Format
Online - Hybrid
Location
Cambridge & Online
Academic Excellence
Specialized Life Sciences Curriculum
✓
Industry-aligned modules bridging the gap between scientific innovation and corporate strategy.
World-Class Executive Faculty
✓
Learn from top-tier practitioners and researchers at the forefront of the global biotech sector.
Strategic Innovation Frameworks
✓
Master the quantitative tools required to evaluate and lead high-growth venture assets.
Global Professional Network
✓
Join a prestigious community of alumni and partners across Cambridge and international hubs.
Enrollment
- Application: Initial submission of professional credentials and academic transcripts through our secure portal.
- Review: Comprehensive evaluation by our Admissions Committee focusing on leadership potential and industry experience.
- Offer: Formal invitation to join the programme issued to selected candidates.
- Registration: Confirmation of place through enrollment documentation and initial tuition deposit.
Join the Next Cohort
ADMISSIONS
The Executive MBA program at BBI Cambridge is designed for ambitious professionals ready to lead in the biotech sector. We accept applications on a rolling basis, allowing you to secure your spot for the upcoming academic session. Start your journey into the intersection of science and strategy today.